Full text
PDFPage 200
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baldessarini R. J., Huston-Lyons D., Campbell A., Marsh E., Cohen B. M. Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiatry Suppl. 1992 May;(17):12–16. [PubMed] [Google Scholar]
- Chouinard G., Jones B., Remington G., Bloom D., Addington D., MacEwan G. W., Labelle A., Beauclair L., Arnott W. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol. 1993 Feb;13(1):25–40. [PubMed] [Google Scholar]
- Grenhoff J., Svensson T. H. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol. 1993 Mar 16;233(1):79–84. doi: 10.1016/0014-2999(93)90351-h. [DOI] [PubMed] [Google Scholar]
- Hirsch S. R., Puri B. K. Clozapine: progress in treating refractory schizophrenia. BMJ. 1993 May 29;306(6890):1427–1428. doi: 10.1136/bmj.306.6890.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers B. R. The antimicrobial activity of cefamandole. Scand J Infect Dis Suppl. 1980;Suppl 25:17–22. [PubMed] [Google Scholar]